Navigation Links
Novartis Drug Diovan Shows Superior Benefits

Results of a Japanese study have given drug giant Novartis AG, more reasons to smile. According to the study published in The Lancet, the company’s blood pressure// drug Diovan was observed to reduce the risks of strokes and cardiovascular events by up to 40 percent.

The study titled the Jikei Heart Study, was based on 3,000 people aged 20 to 79, with high blood pressure, ischemic heart disease or congestive heart failure. The study which was published recently in The Lancet, showed that Diovan produced a 39 percent reduction in cardiovascular events and a 40 percent cut in strokes.

The study compared Diovan when added to a conventional non-angiotensin receptor blocker (ARB) versus the non-ARB therapy alone. Accordingly, the superior benefits reported with Diovan led to an early termination of the study.

In addition to its impact on overall cardiovascular events and stroke, other benefits of Diovan demonstrated were: relative reductions of 65 percent in angina pectoris, 46 percent in heart failure and 81 percent in aortic dissection - separation of the wall layers in the body's main artery – as compared to other treatment groups.

There were few adverse events (2.5 percent overall) with no significant difference in tolerability between the groups. According to investigators, these effects were reported independently of blood pressure reductions.

Says Gordon McInnes, Professor of Medicine at the Western Infirmary in Glasgow, Scotland:"The results of this trial carry an important clinical message for physicians across the globe who are trying to protect patients from debilitating complications such as stroke. "Jikei Heart tells us that adding Diovan to usual treatment regimens can offer substantial long-term protection”, he added.

The Jikei Heart Study is the first controlled trial to assess the cardiovascular benefits of adding the angiotensin receptor blocker, or ARB, Diovan to conventional non-A
'"/>




Page: 1 2

Related medicine news :

1. Novartis files application with FDA for Zometa
2. Canine Painkiller unveiled by Novartis
3. Glivec the hot cancer drug from Novartis
4. Zometa [Novartis Drug] For Treatment Of Paget’s Diseas
5. Novartis MS Drug Shows Promising Results
6. Bird-flu Vaccine Adjuvant Contract Goes to Novartis
7. Drop Patent Petition, Activists Ask Novartis
8. E.U. Panel Backs Novartis Mock-up Pandemic Flu Vaccine
9. Indian Court Refers Novartis Plea for Patent on Anti-cancer Drug to a Separate Board
10. Novartis Gleevec Found Effective in Treating Gastro-intestinal Tumors
11. Experimental treatment for Ebola Virus Shows promising results in mice
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Novartis Drug Diovan Shows Superior Benefits

(Date:11/24/2014)... (PRWEB) November 24, 2014 Olaparib functions ... polymerase (PARP) and is one of the first PARP ... to creating some types of melanoma, and are often ... also sometimes gives their malignancies a exclusive weaknesses, as ... to fix their DNA and allow them to proceed ...
(Date:11/24/2014)... The Holiday Inn Westbury - Long ... Children's Association to donate various items consisting of ... other such items.The Association's program is aimed toward helping ... in nursing homes, assisted living facilities and nursing homes. ... being of seniors throughout the Long Island area. The ...
(Date:11/24/2014)... Raymond, Alberta (PRWEB) November 24, 2014 ... of people each day. They break up families, ... there is new hope for those that suffer,” ... “Ground-breaking scientific research is showing that our specialized ... , Hardy will appear on “Mind Over Matter”, ...
(Date:11/24/2014)... SafeHandles™ announced that they will be featured in ... airing via Discovery Channel. Dates and show times TBA. ... replaceable, and affordable germ protective device. This segment will ... adhesives to promote hand hygiene in high traffic and ... is the desire to make a positive impact in ...
(Date:11/24/2014)... Gersowitz Libo & Korek, P.C., a leading ... Tier recognition in the 2015 Edition of U.S. News-Best Lawyers ... a unique combination of quality law practice and breadth of ... honor and especially grateful to our clients whose continued support ... possible,” said Jeff S. Korek, senior partner at Gersowitz ...
Breaking Medicine News(10 mins):Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 2Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 3Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 4Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2
... Sept. 21 Roper Industries,Inc. (NYSE: ROP ) ... 2007, ended September 30, 2007, will be released after ... call to discuss these results,has been scheduled for 10:00 ... be accessed via webcast or by dialing +1 888-801-6506 ...
... SAN DIEGO, Sept. 21 ChemDiv, Inc. (San ... (CDRI, Moscow) is,undertaking a partnership with the Blokhin ... Medical Sciences, the US Department of Energy,(DOE), and ... novel small,molecule therapies for the prevention and treatment ...
... On Sept. 18, the,Michigan Association of Health Plans ... award reception at which eight Michigan HMOs received,the ... as these,are leading the way in serving participants ... "Michigan needs more,health care plans that expand outreach, ...
... are at high risk for preterm birth, giving them a ... babys chances of having serious lung problems after birth. , ... new study shows that repeat courses of corticosteroids are linked ... these mothers. , Our study shows that you get almost ...
... of studies shows big survival gains , THURSDAY, ... regimens of irinotecan, oxaliplatin, and molecular-targeted treatments are ... months longer than they did a few years ... say. , Researchers at the University of Ioannina ...
... 18, 2007 -- Recently, researchers at Iowa State University ... popular crop model. By zeroing in on early stages ... help improve yield predictions across a variety of environmental ... the September-October issue of Crop Science. , The Crop ...
Cached Medicine News:Health News:Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership 2Health News:Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership 3Health News:Eight Michigan HMOs, Two Providers, Take Top Honors for Quality Health Care 2Health News:Eight Michigan HMOs, Two Providers, Take Top Honors for Quality Health Care 3Health News:Multiple corticosteroid injections in pregnant women may increase cerebral palsy 2Health News:Experts Compare Colon Cancer Treatment Outcomes 2Health News:Simulating kernel production influences maize model accuracy 2
(Date:11/24/2014)... YORK , Nov. 24, 2014  Relmada Therapeutics, ... for the treatment of chronic pain, announced today that ... to present at the LD MICRO "MAIN Event" Micro-Cap ... will be held at the Luxe Sunset Bel Air ... Los Angeles, California . ...
(Date:11/24/2014)... Theater, LLC, announced today that their technology will be ... Europe,s first simulation center, The ... Planner (SRP) and the Surgical Navigation Advanced Platform (SNAP) ... navigation and augmented reality capabilities in the operating room ... Department of Neurosurgery at Mount Sinai Health System in ...
(Date:11/24/2014)... novembre 2014  Surgical Theater LLC ha ... esposta durante l,apertura in data 24 novembre ... la Fondazione IRCCS Istituto Neurologico Nazionale "C. ... (strumento di pianificazione chirurgica) e Surgical Navigation ... avanzata) saranno presentati in occasione dell,evento dedicato ...
Breaking Medicine Technology:Relmada Therapeutics To Present At LD MICRO Conference 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 3La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 2La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 3La tecnologia di Surgical Theater in mostra in Italia all'apertura del centro Besta NeuroSim di Milano 4
... and TORONTO, Feb. 27, 2012 Generex Biotechnology Corporation ... President of Generex subsidiary Antigen Express, Inc., will give ... be held in Boston, MA February 27-29.  The presentation, ... the Role of Th cells," will be given Wednesday, ...
... WHAT: Gearing up for its 2012 multi-city tour, the first stop ... with the Coconut Grove Chamber of Commerce, along with input ... has listed the "Top 25 Sights to See" in Miami ... – tourists and Miami locals alike – to vote on ...
Cached Medicine Technology:Generex Subsidiary Antigen Express to Present at Prestigious Cancer Immunotherapy Summit 2Generex Subsidiary Antigen Express to Present at Prestigious Cancer Immunotherapy Summit 3Generex Subsidiary Antigen Express to Present at Prestigious Cancer Immunotherapy Summit 4Transitions Optical Kicks-Off 2012 Multi-City "Sightseeing City Tour" with Voting Contest for "Top 10 Sights to See" in Miami 2
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
... For Anterior and Posterior segment surgeries ... using Ventury or Peristaltic Linear Aspiration. ... for specific cutting action. Easy to ... movement. Cutting speed-variable from 1- 600 ...
Medicine Products: